publication date: May. 18, 2018

Funding Opportunities

NETRF Announces grant funding for neuroendocrine cancer research

The Neuroendocrine Tumor Research Foundation announced its latest Request for Applications and invites innovative research applications in neuroendocrine tumors that can bring the field closer to more effective therapies.

This uncommon cancer occurring in hormone-producing cells is often overlooked for research funding. NETRF serves as the major private funder of NET cancer research.

To ensure that high-quality, meaningful research proposals are selected, NETRF uses a rigorous peer review process, which includes external expert reviewers and a Board of Scientific Advisors.  

Interested applicants must submit a letter of intent by June 13. From that pool, exceptional investigators with the most promising and transformative ideas will be invited to submit full proposals. Grant awards will be announced in December 2018.

Last year NETRF invested heavily in a targeted form of radiation called peptide receptor radionuclide therapy.

Since 2005, NETRF has funded $20 million in scientific research grants to expand the molecular understanding of NETs and help drive personalized treatment options for patients. NET research projects have been funded in the U.S., Canada, United Kingdom, Switzerland, Australia, and the Netherlands.


Colorectal Cancer Alliance announces up to $775,000 in available research funding

The Colorectal Cancer Alliance announced up to $775,000 in available funding for research in young-onset colorectal cancer, rectal cancer, and colorectal cancer prevention. The Alliance will award up to five research grants for work that will advance its mission of ending colorectal cancer within our lifetime.

The grants will be awarded through the Chris4Life Research Program, which was established in 2010 to honor the late Christine Sapienza and all who are affected by colorectal cancer. The Alliance is committed to investing $10 million in critical research by 2021, including $3 million specifically to young-onset colorectal cancer research.

Additional funding for rectal cancer research may become available pending further financial support.

Proposals will be accepted now through October 1 online.

Grant recipients will be notified in December, with funding to commence in January 2019. More information about each grant:


Young-onset colorectal cancer research grants

Up to three 2-year grants in the amount of $125,000 each will be awarded to support research in young-onset colorectal cancer. The focus of research could be, but is not limited to, the following:

  • The risk factors and causes associated with the rise in young-onset colorectal cancer.

  • Prevention and early detection strategies.

  • Better mechanisms for increasing long-term survival rates.

  • The psychosocial impacts of young-onset colorectal cancer and the overall social influence on daily survivorship.


Rectal cancer research grant

One 2-year grant in the amount of $250,000 will be awarded to support research on rectal cancer research. The focus of research could be, but is not limited to, the following:

  • The risk factors and causes associated with the rise in rectal cancer in adults 55 and younger.

  • Prevention and early detection strategies.

  • Better mechanisms for increasing long-term survival rates.

  • The psychosocial impacts of rectal cancer and the overall social influence on daily survivorship.

  • The exploration and recommendations for improvements in the number of cases associated with Low Anterior Resection Syndrome.


Prevention research grant

One grant in the amount of $150,000 will be awarded over a two-year period to support the work of a researcher while working on mentored, colorectal cancer prevention research. The focus of research could be, but is not limited to, the following:

  • Improving colorectal cancer screening compliance.

  • Improving patient understanding of colonoscopy results, especially implications for diagnosis of advanced adenoma as it pertains to personal and family risk.

  • Preventing colorectal cancer and/or advanced adenoma recurrence.

The goal of the Colorectal Cancer Alliance’s research program is to provide funding for innovative projects expected to lead to future funding from other peer-reviewed sources.

Copyright (c) 2018 The Cancer Letter Inc.